www.iterumtx.com Open in urlscan Pro
3.124.179.217  Public Scan

Submitted URL: http://www.iterumtx.com/
Effective URL: https://www.iterumtx.com/
Submission: On September 18 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

GET /search

<form action="/search" method="get">
  <label for="search-default" class="sr-only">Search Term</label>
  <input type="text" name="q" id="search-default" placeholder="Search">
  <button type="submit"><span class="glyphicon glyphicon-search"></span></button>
</form>

Text Content

This website uses cookies to help us provide you with a more responsive and
personalized service. By using this website without changing your cookie
settings, you agree to our use of cookies. For more information on how we use
cookies and how to delete or block the use of cookies, please see our Cookies
Policy.
Accept

Search Term



 * Home
 * About Us
   * Our Company
   * Senior Management
   * Board of Directors
   * Venture Investors
 * Our Science
   * Our Challenge
   * Our Promise
   * Pipeline
   * Publications
 * Investors
   * Overview
   * Press Releases
   * Events & Presentations
   * Financials & Filings
   * Stock Information
   * Analyst Coverage
   * Corporate Governance
   * FAQ
 * News
   * Press Releases
   * External News Links
 * Careers
   * Career Opportunities
 * Contact Us
   * Global Locations
   * Partnering Opportunities
 * Search

Back to top


OUR CHALLENGE


ANTIBIOTIC RESISTANT INFECTIONS

Every year, at least two million Americans are infected with bacteria that
resist antibiotics. At least 23,000 people die as a direct result. Multi-drug
resistant pathogens are a global crisis. Physicians and patients urgently need
new options.

Learn More


OUR PROMISE


NEW EFFECTIVE ORAL TREATMENTS

Responding to specific medical need, Iterum is developing sulopenem - the first
oral and IV penem antibiotic demonstrating a potent spectrum of activity against
multi-drug resistant gram-negative infections in both the hospital and community
settings

Learn More

Tackling serious challenges, delivering unique solutions


ABOUT US

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to
developing significantly differentiated anti-infectives aimed at combating the
global crisis of multi-drug resistant (MDR) pathogens.

Our Company


CAREERS

Our culture is defined by collaboration and a shared motivation to leverage the
power of ingenuity to develop new solutions that address the ever-increasing
global threat of resistant bacterial infections.

Career Opportunities


INVESTORS

September 16, 2022 3:59 PM EDT


MARKET/SYMBOL

Nasdaq: ITRM


LAST

$1.92


CHANGE

-0.08 (-4.00%)


VOLUME

123.59k


DAY RANGE

1.84 - 2.0101


YEAR RANGE

1.84 - 11.25
View Investors


Iterum Therapeutics plc Fitzwilliam Court, 1st Floor. Leeson Close. Dublin 2,
D02 YW24. Ireland.

All Rights Reserved. Iterum Therapeutics plc 2022. Terms of Use Privacy
Statement Cookies Statement
Home About Us Our Science Investors News Careers Contact Us Search Sitemap

Market Data copyright © 2022 QuoteMedia. Data delayed 15 minutes unless
otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End
of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.